Rezultati pretrage - Zhuo, Jianyong

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases od Yang, Xinyu, Lu, Di, Zhuo, Jianyong, Lin, Zuyuan, Yang, Modan, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

The ongoing trends of patient‐derived xenograft models in oncology od Zhuo, Jianyong, Su, Renyi, Tan, Winyen, Lian, Zhengxing, Lu, Di, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Laparoscopic management of enterohepatic migrated fish bone mimicking liver neoplasm: A case report and literature review od Chen, Jun, Wang, Chao, Zhuo, Jianyong, Wen, Xue, Ling, Qi, Liu, Zhikun, Guo, Haijun, Xu, Xiao, Zheng, Shusen

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma od Zhang, Xuanyu, Zhuang, Runzhou, Ye, Qianwei, Zhuo, Jianyong, Chen, Kangchen, Lu, Di, Wei, Xuyong, Xie, Haiyang, Xu, Xiao, Zheng, Shusen

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1 od Ling, Sunbin, Xie, Haiyang, Yang, Fan, Shan, Qiaonan, Dai, Haojiang, Zhuo, Jianyong, Wei, Xuyong, Song, Penghong, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma od Wang, Jianguo, Zhuo, Jianyong, Tao, Yaoye, Xu, Shengjun, Chen, Zun, Yang, Fan, Ke, Qinghong, Xie, Haiyang, Zheng, Shusen, Wang, Hangxiang, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts od Zhuo, Jianyong, Lu, Di, Wang, Jianguo, Lian, Zhengxing, Zhang, Jiali, Li, Huihui, Cen, Beini, Wei, Xuyong, Wei, Qiang, Xie, Haiyang, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma od Zhuang, Runzhou, Lu, Di, Zhuo, Jianyong, Zhang, Xuanyu, Wang, Kun, Wei, Xuyong, Wei, Qiang, Wang, Wei, Xie, Haiyang, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma od Lu, Di, Yang, Fan, Zhuo, Jianyong, Yang, Modan, Lin, Zuyuan, Jin, Pingbo, Cai, Xuechun, Cen, Beini, Wang, Jianguo, Wei, Xuyong, Zheng, Shusen, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study od Shen, Xiaoyong, Yang, Fan, Yang, Pengfei, Yang, Modan, Xu, Lei, Zhuo, Jianyong, Wang, Jianguo, Lu, Di, Liu, Zhikun, Zheng, Shu-sen, Niu, Tianye, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation od Yang, Xinyu, Lu, Di, Wang, Rui, Lian, Zhengxing, Lin, Zuyuan, Zhuo, Jianyong, Chen, Hao, Yang, Modan, Tan, Winyen, Yang, Mengfan, Wei, Xuyong, Wei, Qiang, Zheng, Shusen, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy od Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst

Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021) od Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib od Zhuo, Jianyong, Lu, Di, Lin, Zuyuan, Yang, Xinyu, Yang, Modan, Wang, Jianguo, Tao, Yaoye, Wen, Xue, Li, Huihui, Lian, Zhengxing, Cen, Beini, Dong, Siyi, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Shen, Youqing, Xu, Xiao

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst